Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Columbia Financial reported Q3 2026 net income of $5.2 million, or $0.02 per share, while declaring a quarterly cash dividend of $0.05 per share. The quarter was marked by the completion of the second-step conversion offering and the acquisition of Northfield Bancorp, which helped drive total assets to $17.6 billion.
“During the quarter, our team successfully completed the second-step conversion offering and simultaneous acquisition of Northfield Bancorp, Inc. (“Northfield”), and executed a series of transactions to improve earnings, reduce interest rate and credit risk on the balance sheet by selling securities and delinquent, nonperforming and criticized and classified assets, as well as, materially reducing our exposure to New York City rent regulated multifamily loans.”
Thomas J. Kemly, President and Chief Executive Officer
“We continue to believe that our approach to community relationship banking, and our disciplined focus on capital deployment will drive strong earnings growth and stockholder returns.”
Thomas J. Kemly, President and Chief Executive Officer
Hims & Hers Health CLO Soleil Boughton Sells $95.6K of Stock
Soleil Boughton, CLO, sold 3,462 shares of Hims & Hers Health, Inc. at $27.60 a share, worth $95.6K in total on Oct 28, 2026. Shares held after the trade: 293,886 (-1.2%).
Stryker reported Q3 2026 net sales of $6.5 billion, representing 7.7% organic growth, though management noted performance fell slightly short of internal expectations. The company also announced a $3.0 billion increase to its share repurchase program and updated its full-year 2026 guidance.
Term
Q3 2026
“We delivered 7.7% organic sales growth and double-digit adjusted earnings growth in the quarter. While, in absolute terms, this reflected good overall performance, it did fall short of our expectations. The underlying fundamentals of the business remain strong, and we expect a solid performance in Q4 and good momentum heading into 2027.”
Farmland Partners Inc. reported a net loss of $15.5 million for the quarter ended September 30, 2026, primarily driven by a $12.0 million asset impairment charge. Total operating revenues decreased to $9.8 million from $11.3 million in the prior year period, while total real estate assets net of depreciation declined to $584.0 million.
LSB Industries reported net income of $16.3 million for the third quarter of 2026, more than doubling the $7.1 million reported in the prior year period. For the nine months ended September 30, 2026, net sales grew to $496.2 million from $450.2 million, driven by improved gross profit margins and operational performance across its chemical manufacturing facilities.
Roblox reported its third quarter 2026 financial results, highlighting a significant inflection point in AI-driven content creation on the platform. The company introduced new initiatives including 'Roblox Everywhere' and 'The Universal Player' to expand its reach to off-platform audiences and older user cohorts.
PURE Bioscience, Inc. is focused on commercializing its proprietary Silver Dihydrogen Citrate (SDC) technology for food safety, including PURE Hard Surface and PURE Control. The company faces significant financial challenges, including a history of losses and a going concern warning from its auditors, necessitating additional capital to maintain operations.
Waste Connections Executive VP Engineering James Little Sells $370K of Stock
James Little, Executive VP Engineering, sold 2,000 shares of Waste Connections, Inc. at $185.22 a share, worth $370K in total on Oct 27, 2026. Shares held after the trade: 32,395 (-5.8%).
Zedge, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.02 per share of Class B common stock. The dividend is payable on or about November 23, 2026, to stockholders of record as of November 9, 2026, reflecting the company's confidence in its free cash flow generation.
Wesbanco, Inc. reported net income available to common shareholders of $258.1 million for the nine months ended September 30, 2026, a significant increase from $124.4 million in the prior year period. This growth was driven by higher net interest income and a substantial reduction in the provision for credit losses compared to 2025.
PTC Therapeutics reported record third-quarter 2026 financial results, with total revenue reaching $358 million, driven by $182 million in sales from the Sephience launch. The company raised its full-year 2026 revenue guidance to a range of $1.29 billion to $1.32 billion and expects to complete its BLA submission for the ST-920 Fabry disease gene therapy in Q4 2026.
“We delivered another strong quarter of record product revenue led by the continued momentum of the Sephience launch, putting us firmly on track to achieve our cash flow breakeven milestone this year. Now at the one-year mark, the launch has been a success by all measures. With a strong patient base, the large global market, and the reports of meaningful treatment benefits, we look forward to continued growth both in the US and internationally.”
Republic Services reported Q3 2026 net income of $592 million ($1.93 per share) on revenue growth of 8.2%, driven by strong pricing and environmental solutions performance. The company raised its full-year 2026 adjusted EBITDA and free cash flow guidance while announcing a new $5 billion share repurchase authorization.
“We delivered strong third quarter results that underscored the resilience of our business model and the effectiveness of our strategy. Positive growth trends across the business and improved performance in Environmental Solutions reinforce our confidence in the opportunities ahead. We remain focused on disciplined pricing, effective cost management and strategic investments that are designed to strengthen our competitive position and create long-term value for our customers and shareholders.”
Jon Vander Ark, president and chief executive officer
Slide Insurance Holdings reported a significant increase in net income to $412.6 million for the nine months ended September 30, 2026, compared to $273.6 million in the prior year. Total revenue grew to $1.14 billion, driven by higher gross premiums earned, while the company maintained a strong liquidity position with total assets of $3.39 billion.
Extreme Networks reported total net revenues of $341.1 million for the quarter ended September 30, 2026, representing a 10% increase year-over-year. Net income rose significantly to $16.0 million compared to $5.6 million in the prior year, driven by higher product gross profits and improved operating leverage despite increased restructuring charges.
Ingram Micro reported record Q3 2026 financial results with net sales of $15.2 billion, up 20.8% year-over-year, driven by strength in Cloud and AI infrastructure. The company also declared a quarterly cash dividend of $0.088 per share and raised its full-year outlook following strong cash flow generation.
Term
Q3 2026
“Our record third-quarter performance reflects the breadth and resilience of our business and continued execution against the strategy we outlined at our Capital Markets Day in September. We delivered broad-based growth across all four regions, and across our primary lines of business, while continuing to scale Xvantage™ and advance our intelligent operating model.”
Paul Bay, Ingram Micro’s chief executive officer
“Our double-digit year-over-year growth is reflective of balanced strength both geographically and by line of business, but remains most robust in Advanced Solutions, including GPU and AI infrastructure as well as Cloud-based Solutions.”
Mike Zilis, Ingram Micro’s chief financial officer
Pebblebrook Hotel Trust reported a net loss of $54.6 million for the third quarter of 2026, compared to a $32.4 million loss in the prior year period, primarily driven by a $77.3 million impairment charge. Total revenues increased slightly to $402.7 million, while the company continued its capital return strategy by repurchasing both common and preferred shares.
Exelixis reported third quarter 2026 total revenues of $658.7 million, driven by $604.9 million in net product revenues from the cabozantinib franchise. The company achieved GAAP net income of $218.1 million and is focused on advancing its zanzalintinib development program and clinical pipeline.
Term
Q3 2026
“Exelixis continued to execute across all of our key priorities in the third quarter, driving the cabozantinib franchise forward while preparing for zanzalintinib as our next potential franchise opportunity. The zanzalintinib development program gained further momentum as the organization focused on trial initiations, enrollment progress for ongoing studies and in-depth planning for the next wave of new pivotal trials.”
Michael M. Morrissey, Ph.D., President and Chief Executive Officer
EVERTEC's Board of Directors declared a regular quarterly cash dividend of $0.05 per share. The dividend is payable on December 4, 2026, to stockholders of record as of November 9, 2026.
Olin Corporation reported third quarter 2026 net income of $14.4 million on sales of $1,747.7 million, while providing an update on its pending merger with Huntsman. The company now expects the Huntsman transaction to close in the first quarter of 2027 following shareholder approval and the expiration of the HSR Act waiting period.
Counterparty
Huntsman
“During the third quarter, Olin delivered adjusted EBITDA consistent with our expectations and restored normal operations at our vinyl chloride monomer (VCM) assets. Our Chlor Alkali Products and Vinyls business maintained disciplined market participation and stable domestic Electrochemical Unit values despite continued challenging global demand.”
Ken Lane, President and Chief Executive Officer
“Our fourth-quarter outlook reflects normal seasonality, as well as elevated year-end customer destocking in Chemicals, higher feedstock costs, continued pressure from subsidized Asian exports and significant planned maintenance turnarounds.”
KLA Corporation reported strong growth for the quarter ended September 30, 2026, with total revenues increasing to $4.14 billion from $3.21 billion in the prior year. Net income rose significantly to $1.55 billion, driven by robust product sales, while the company returned over $1.2 billion to stockholders through share repurchases and dividends.
SPS Commerce reported Q3 2026 revenue of $197.6 million, a 4% increase year-over-year, despite the divestiture of its 3P Revenue Recovery business. Net income rose to $30.7 million ($0.85 per diluted share) as the company advanced its AI-driven 'agentic' strategy and expanded Adjusted EBITDA margins to 34%.
Term
Q3 2026
“The progress we have made to date with our agentic transformation initiatives – both across our product portfolio and internally – has exceeded my expectations. I want to recognize all of Team SPS for their agentic-first mindset and commitment to this transformation.”
Chad Collins, CEO of SPS Commerce
“Our third quarter financial results clearly demonstrate the strong operating leverage embedded in our business model. Continued margin expansion underscores both our commitment to disciplined cost management and the tangible efficiency gains we're unlocking through agentic customer onboarding.”
Coinbase Global, Inc. published its Q3 2026 Earnings Presentation and announced a Q&A session to discuss its financial results for the quarter ended September 30, 2026. The filing serves as a Regulation FD disclosure, providing the presentation deck as an exhibit for investors and analysts.
Reddit reported third quarter 2026 financial results, featuring 53% year-over-year revenue growth to $895 million and net income of $283 million. The company also highlighted strong user growth with Daily Active Uniques (DAUq) increasing 12% to 130.3 million and its recent addition to the S&P 500 index.
“Our business is growing because the Reddit experience captures the human experience in a way that no other platform can replicate. Surpassing $3B of revenue over the last 12 months shows Reddit’s strength as a destination and the differentiated value of our platform.”
Weyerhaeuser reported Q3 2026 net earnings of $61 million on net sales of $1.9 billion, with Adjusted EBITDA increasing 14% year-over-year to $248 million. The company also announced an agreement to divest 81,000 acres of non-core timberlands in Arkansas for $146 million and highlighted progress in its Natural Climate Solutions business, including biocarbon facility construction and carbon credit monetization.
Term
Q3 2026
“Our teams delivered solid operating performance in the third quarter against an increasingly challenging macroeconomic backdrop. In addition, we continued to enhance the value of our timberlands portfolio and made meaningful progress advancing several strategic growth initiatives.”
Devin W. Stockfish, president and chief executive officer
“Looking ahead, we remain confident in the longer-term demand fundamentals that support growth for our businesses and are well positioned to navigate the current environment given the strength of our portfolio, balance sheet and flexible capital allocation framework.”
Devin W. Stockfish, president and chief executive officer
Intel reported third-quarter 2026 revenue of $16.5 billion, up 21% year-over-year, driven by record data center growth. The company also provided fourth-quarter revenue guidance of $15.0 billion to $16.0 billion, noting expectations of a continued PC market slowdown through the first half of 2027.
Term
Q3 2026
“Our Q3 results demonstrate improving execution, meaningful progress expanding supply and continued advancement of our process technology. Despite near-term headwinds across the PC industry, demand for our CPUs remains robust, reinforcing our confidence in the long-term growth opportunities for our business.”
Lip-Bu Tan, Intel CEO
“We delivered another solid quarter. Revenue, gross margin and earnings per share exceeded guidance, including our strongest data center revenue growth in 15 years.”
Alamar Biosciences 10% Owner Qiming Corporate GP VI Ltd. Sells $5.96M of Stock
Qiming Corporate GP VI Ltd., 10% Owner, sold 185,597 shares of Alamar Biosciences, Inc. at $30.33 to $33.11 a share (average $32.14) in 19 transactions, worth $5.96M in total between Oct 27, 2026 and Oct 28, 2026. Shares held after the trade: 1,704,596 (-0.5%).
Supernus Pharmaceuticals reported record Q3 2026 total revenues of $226.8 million, an 18% increase year-over-year, driven by strong performance from growth products like Qelbree and ZURZUVAE. The company also announced that its pending merger with Indivior Pharmaceuticals is expected to close on November 2, 2026. Additionally, the FDA recognized seven years of orphan-drug exclusivity for its Parkinson’s disease treatment, ONAPGO.
Counterparty
Indivior Pharmaceuticals, Inc.
Term
Q3 2026
“Our strong operating execution year-to-date delivered total revenue growth of 29%, which shows the continued momentum across our commercial portfolio, specifically our growth products. We look forward to closing the merger with Indivior next week, which will create a diverse CNS biopharmaceutical leader positioned to serve more patients and deliver long-term value for shareholders.”
Jack Khattar, President and Chief Executive Officer
eBay Inc. reported its third-quarter 2026 financial results, highlighting steady revenue growth driven by its advertising business and focus categories. The company maintained its full-year guidance while continuing its share repurchase program and dividend payments.
Ryan Specialty Holdings reported Q3 2026 financial results with total revenue growing 4.7% year-over-year to $790.0 million and net income of $88.0 million. The company also declared a regular quarterly dividend of $0.13 per share and returned $173.7 million to shareholders during the quarter through buybacks and dividends.
Term
Q3 2026
“We are proud of our third quarter performance, in light of an increasingly challenging market and against our toughest year over year comparison. We grew total revenue 4.7%, driven by organic growth of 4.0%. We grew Adjusted EBITDAC by 3.8% and Adjusted Diluted EPS by 8.5%.”
Patrick G. Ryan, Founder and Executive Chairman
“Our team delivered in the face of one of the most challenging markets we have ever seen, retaining high levels of existing business, winning significant new business, and building our pipelines. We continue to deliver for our clients through our differentiated talent, deep specialty expertise, and independence.”
TFS Financial reported record net income of $100.7 million for the fiscal year ended September 30, 2026, a 10.7% increase over the prior year. The results were driven by a 9.9% increase in net interest income and a net interest margin improvement to 1.88%, despite a rise in non-interest expenses related to core banking system investments.
Term
FY2026
“This year was another milestone for Third Federal, passing $100 million in net income, driven by continued net margin improvement to 1.88%, and a 39% increase in mortgage loan originations from 2025. With the significant investment we made in a new core banking system and a strong Tier 1 capital leverage ratio of 10.53%, we are well-positioned to continue to grow and effectively serve our customers.”